Selective delivery of adiramycin to a solid tumor using a polymeric micelle carrier system

Journal of Drug Targeting

Volumn 7, Issue 3, 1999, Pages 171-186

  Yokoyama, M ^a   Okano, T ^a   Sakurai, Y ^a   Fukushima, S ^b   Okamoto, K ^b   Kataoka, K ^c  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b NIPPON KAYAKU CO LTD   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

Adriamycin; Doxorubicin; Drug targeting; Passive targeting; Polymeric micelle

Indexed keywords

ANTINEOPLASTIC AGENT; DOXORUBICIN; DRUG CARRIER; ANTINEOPLASTIC ANTIBIOTIC;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; COLON ADENOCARCINOMA; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG TARGETING; FEMALE; MAXIMUM PERMISSIBLE DOSE; MICELLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SOLID TUMOR; ADENOCARCINOMA; ANIMAL; CHEMISTRY; COLON TUMOR; FECES; FISCHER 344 RAT; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; MALE; RAT; TISSUE DISTRIBUTION;

ADENOCARCINOMA; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COLONIC NEOPLASMS; DOXORUBICIN; DRUG CARRIERS; FECES; FEMALE; INJECTIONS, INTRAVENOUS; MALE; MICELLES; RATS; RATS, INBRED F344; TISSUE DISTRIBUTION;

EID: 0033233187     PISSN: 1061186X     EISSN: None     Source Type: Journal    
DOI: 10.3109/10611869909085500     Document Type: Article

References (39)

1. Abchowski, A., McCoy, J.R., Palczuk, N.C., van Es, T. and Davis, F.F. (1977) Effect of covalent attachment of polyethylene glycol on immunogenicity and circulating life of bovine liver catalase. J. Biol. Chem., 252, 3582-3586.
2. Cummings, J., Merry, S. and Willmott, N. (1986) Disposition kinetics of adriamycin, adriamycinol and their 7-deoxyglycones in AKR mice bearing a sub-cutaneously growing ridgway osteogenic sarcoma (ROS). Eur. J. Cancer Clin. Oncol., 22, 451-460.
3. De Leeuw, A.M., Brouwer, A. and Knook, D.L. (1990) Sinusoidal endothelial cells of the liver: Fine structure and function in relation to age. J. Electron Microscopy Technique, 14, 218-236.
4. Dvorak, H.F., Brown, L.F., Detmar, M. and Dvorak, A.M. (1995) Vascular permeability factor vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am. J. Pathol., 146, 1029-1039.
5. Duncan, R., Dimitrijevic, S. and Evagorou, E.G. (1996) The role of polymer conjugates in the diagnosis and treatment of cancer. S. T. P. Pharma. Sci., 6, 237-263.
6. Forssen, E.A., Coulter, D.M. and Proffitt, R.T. (1992) Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. Cancer Res., 52, 3255-3261.
7. Gabizon, A., Price, D.C., Huberty, J., Bresalier, R.S. and Papahadjopoulos, D. (1990) Effect of liposome composition and other factors on the targeting of liposomes to experimental tumors: Biodistribution and imaging studies. Cancer Res., 50, 6371-6378.
8. Huang, S.K., Mayhew, E., Gilani, S., Lasic, D.D., Martin, F.J. and Papahadjopoulos, D. (1992) Pharmacokinetics and therapeutics of sterically stabilized liposomes in mice bearing C-26 colon tumor. Cancer Res., 52, 6774-6781.
9. Kabanov, A.V., Batrakova, E.V., Melik-Nubarov, Fedoseev, N.A., Dorodnich, T.Y., Alakhov, V.Y., Chekhonin, V.P., Nazarova, I.R. and Kabanov, V.A.A. (1992) A new class of drug carriers: Micelles of poly(oxyethylene)-poly(oxypropylene) block copolymers as microcontainers for drug targeting from blood in brain. J. Contr. Rel., 22, 141-158.
10. Katre, N.V., Knauf, M.J. and Laird, W.J. (1987) Chemical modification of recombinant interleukin 2 by polyethylene glycol increases its potency in the murine Meth A sarcoma model. Proc. Natl. Acad. Sci. (USA). 84, 1487-1491.
11. Kohn, S., Nagy, J.A., Dvorak, H.F. and Dvorak, A.M. (1992) Pathways of macromolecular tracer transport across venules and small veins: Structural basis for the hyperpermeability of tumor blood vessels. Lab. Invest., 67, 596-607.
12. Kopecek, J., Rejmanova, P. and Chytry, V. (1981) Polymers containing enzymatically degradable bonds, I. Chymotrypsin catalysed hydrolysis of p-nitroanilides of phenylalanine and tyrosine attached to side-chains of copolymers of N-(2-hydroxypropyl)methacrylamide. Makromol. Chem., 182, 799-801.
13. Kwon, G.S., Yokoyama, M., Okano, T., Sakurai, S. and Kataoka, K. (1993) Biodistribution of micelle-forming polymer drug conjugates. Pharm. Res., 10, 970-974.
14. Kwon, G.S., Yokoyama, M., Okano, T., Sakurai, S. and Kataoka, K. (1994a) Enhanced tumor accumulation and prolonged circulation times of micelle-forming poly(ethylene oxide-aspartate) block copolymer adriamycin conjugates. J. Contr. Rel., 29, 17-23.
15. Kwon, G.S., Naito, M., Kataoka, K., Yokoyama, M., Sakurai, Y. and Okano, T. (1994b) Block copolymer micelles as vehicles for hydrophobic drugs. Colloids and Surfaces B: Biointerfaces, 2, 429-434.
16. Kwon, G.S., Naito, M., Kataoka, K., Yokoyama, M., Okano, T. and Sakurai, Y. (1995) Physical entrapment of doxorubicin in AB block copolymer micelles. Pharm. Res., 12, 192-195.
17. Kwon, G.S., Naito, M., Yokoyama, M., Okano, T., Sakurai, Y. and Kataoka, K. (1997) Block copolymer micelles for drug delivery: Loading and release of doxorubicin. J. Contr. Rel., 48, 195-201.
18. Lasic, D.D., Martin, F.J., Gabizon, A., Huang, S.K. and Papahadjopoulos, D. (1991) Sterically stabilized liposomes: A hypothesis on the molecular origin of the extended circulation times. Biochim. Biophys. Acta, 1070, 187-192.
19. Litzinger, D.C., Buiting, A.M.J., van Roojen, N. and Huang, L. (1994) Effect of liposome size on the circulation time and intraorgan distribution of amphipathic poly(ethylene glycol)-containing liposomes. Biochim. Biophys. Acta, 1190, 99-107.
20. Maeda, H., Seymour, L.W. and Miyamoto, Y. (1992) Conjugates of anticancer agents and polymers: Advantages of macromolecular therapeutics in vivo. Bioconjugate Chem., 3, 351-362.
21. Matsumura, Y. and Maeda, H. (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: Mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res., 46, 6387-6392.
22. McCready, D.R., Balch, C.M., Fidler, I.J. and Murray, J.L. (1989) Lack of comparability between binding of monoclonal antibodies to melanoma cells in vitro and localization in vivo. J. Natl. Cancer. Inst., 81, 682-687.
23. Pai, L.H., Wittes, R., Setser, A., Willingham, M.C. and Pastan, I. (1996) Treatment of advanced tumors with immunotoxin LMB-1: An antibody linked Pseudomonas exotoxin. Nature Medicine, 2, 350-353.
24. Putnam, D. and Kopecek, J. (1995) Polymer conjugates with anticancer activity. Adv. Polym. Sci., 122, 55-123.
25. Rolland, A., O'mullane, J., Goddard, P., Brookman, L. and Petrak, K. (1992) New macromolecular carriers for drugs. I. Preparation and characterization of poly(oxyethylene-b-isoprene-b-oxyethylene) block copolymer aggregates. J. Appl. Polym. Sci., 44, 1195-1203.
26. Senger, D.R., Galli, S.J., Dvorak, A.M., Perruzzi, C.A., Harvey, V.S. and Dvorak, H.F. (1983) Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science, 219, 983-985.
27. Seymour, L.W., Miyamoto, Y., Maeda, H., Brereton, M., Strohalm, J., Ulbrich, K. and Duncan, R. (1995) Influence of molecular weight on passive tumour accumulation of a soluble macromolecular drug carrier. Eur. J. Cancer, 31A, 766-770.
28. Tardi, P.G., Boman, N.L. and Cullis, P.R. (1996) Review: Liposomal doxorubicin. J. Drug Targeting, 4, 129-140.
29. Tomlinson, E. (1986) (Paso)physiology and the temporal and spatial aspects of drug delivery. In Tomlinson, E. and Davis, S.S. (Eds.) Site-Specific Drug Delivery (Wiley & Sons Ltd.), pp. 1-26.
30. Trail, P.A., Wilner, D., Lasch, S.J., Henderson, A.J., Hofstead, H., Casazza, A.M., Firestone, R.A., Hellström, I. and Hellström, K.E. (1993) Cure of xenografted human carcinomas by BR96-doxorubicin immunoconjugates. Science, 261, 212-215.
31. Wish, L., Furth, J. and Storey, R.H. (1950) Direct determinations of plasma, cell, and organ-blood volumes in normal and hypervolemic mice. Proc. Soc. Exp. Biol. And Med., 74, 644-648.
32. Woodle, M.C. and Lasic, D.D. (1992) Sterically stabilized liposomes. Biochim. Biophys. Acta, 1113, 171-199.
33. Yesair, D.W., Schwartzbach, E., Shunk, D., Denine, E.P. and Asbell, M.A. (1972) Comparative pharamacokinetics of daunomycin and adriamycin in several animal species. Cancer Res., 32, 1177-1183.
34. Yokoyama, M., Miyauchi, M., Yamada, N., Okano, T., Sakurai, Y., Kataoka, K. and Inoue, S. (1990) Characterization and anticancer activity of the micelle-forming polymeric anticancer drug doxorubicin-conjugated poly(ethylene glycol)-poly (aspartic acid) block copolymer. Cancer Res., 50, 1693-1700.
35. Yokoyama, M., Okano, T., Sakurai, Y., Ekimoto, H., Shibazaki, C. and Kataoka, K. (1991) Toxicity and antitumor activity against solid tumors of micelle-forming polymeric anticancer drug and its extremely long circulation in blood. Cancer Res., 51, 3229-3236.
36. Yokoyama, M., Kwon, G.S., Okano, T., Sakurai, Y., Ekimoto, H., Okamoto, K., Mashiba, H., Seto, T. and Kataoka, K. (1993) Composition-dependent in vivo antitumor activity of doxorubicin-conjugated polymeric micelle against murine colon adenocarcinoma 26. Drug Delivery, 1, 11-19.
37. Yokoyama, M., Okano, T., Sakurai, Y. and Kataoka, K. (1994) Improved synthesis of doxorubicin-conjugated poly(ethylene oxide)-poly(aspartic acid) block copolymer and formation of unimodal micellar structure with controlled amount of physically entrapped doxorubicin. J. Contr. Rel., 32, 269-277.
38. Yokoyama, M. and Okano, T. (1997) Targetable drug carriers: Present status and a future perspective. Adv. Drug Delivery Rev., 21, 77-80.
39. Yokoyama, M., Fukushima, S., Vehara, R., Okamoto, K., Kataoka, K., Sakurai, Y. and Okano, T. (1998) Characterization of physical entrapment and chemical conjugation of adriamycin in polymeric micelles and thier design for in vivo delivery to a solid tumor. J. Contr. Rel., 50, 79-92.